{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:17:14Z","timestamp":1791256634510,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018434","name":"Asian Institute of Medicine, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2020\/STG01\/AIMST\/01\/1"],"award-info":[{"award-number":["FRGS\/1\/2020\/STG01\/AIMST\/01\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110153","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:35:00Z","timestamp":1782171300000},"page":"110153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Coumarin-derived oxadiazoles as potential antiviral agents against coronaviruses"],"prefix":"10.1016","volume":"180","author":[{"given":"Mohammad Auwal","family":"Sa'ad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manickam","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitha","family":"Pattabhiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivkanya","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerasamy","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizul Fikri Mohd","family":"Yusop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj Kumar","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110153_bb0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-pathol-052620-121224","article-title":"Comparative pathogenesis of severe acute respiratory syndrome coronaviruses","volume":"19","author":"Zhang","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12985-024-02342-w","article-title":"SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression","volume":"21","author":"Hussein","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.bioorg.2026.110153_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00531-24","article-title":"Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection","author":"Adair","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00705-020-04914-x","article-title":"Circulation of human coronaviruses OC43 and 229E in C\u00f3rdoba, Argentina","volume":"166","author":"Ottogalli","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1325346","article-title":"Avian infectious bronchitis virus (AIBV) review by continent","volume":"14","author":"Rafique","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0030","first-page":"13","article-title":"Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world","author":"Chavda","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0035","first-page":"133","article-title":"Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity","author":"Aguilar-Bretones","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2026.110153_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/v15040947","article-title":"Use of remdesivir in patients with SARS-CoV-2 pneumonia in a real-life setting during the second and third COVID-19 epidemic waves","volume":"15","author":"Marocco","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.110153_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40121-023-00760-x","article-title":"Safety and efficacy of paxlovid against omicron variants of coronavirus disease 2019 in elderly patients","volume":"12","author":"Weng","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.bioorg.2026.110153_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12985-024-02370-6","article-title":"Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development","volume":"21","author":"Ghasemiyeh","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.bioorg.2026.110153_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41980","article-title":"SARS-CoV-2 drug resistance and therapeutic approaches","volume":"11","author":"Batool","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2026.110153_bb0060","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 main protease (Mpro): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.110153_bb0065","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/med.21783","article-title":"What coronavirus 3C-like protease tells us: from structure, substrate selectivity, to inhibitor design","volume":"41","author":"Xiong","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110153_bb0070","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1021\/acsinfecdis.1c00237","article-title":"Recognition of divergent viral substrates by the SARS-CoV-2 Main protease","volume":"7","author":"MacDonald","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110153_bb0075","doi-asserted-by":"crossref","first-page":"11886","DOI":"10.1128\/JVI.01528-14","article-title":"Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance","volume":"88","author":"Deng","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0080","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","article-title":"Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening","volume":"3","author":"Zhu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication\u2013transcription complexes and their relevance for SARS-CoV-2 drug design","volume":"23","author":"Malone","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2024.101973","article-title":"SARS-CoV-2 replication and drug discovery","volume":"77","author":"Nazir","year":"2024","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.bioorg.2026.110153_bb0095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.str.2026.01.003","article-title":"Structural basis for pan-coronavirus inhibition of 3CL protease","volume":"34","author":"Reddem","year":"2026","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2026.110153_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102667","article-title":"Structural biology of SARS-CoV-2 Mpro and drug discovery","volume":"82","author":"Duan","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.948553","article-title":"Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals","volume":"10","author":"Bafna","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acscentsci.2c01359","article-title":"Development of highly potent noncovalent inhibitors of SARS-CoV-2 3CLpro","volume":"9","author":"Hou","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0115","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2174\/1568026623666230126104156","article-title":"SAR based review on diverse heterocyclic compounds with various potential molecular targets in the fight against COVID-19: a medicinal chemist perspective","volume":"23","author":"Madan","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0120","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/ijms21134618","article-title":"An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities","volume":"21","author":"Annunziata","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0125","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.14233\/ajchem.2024.31430","article-title":"In silico analysis of antiviral potential of new coumarin analogues against coronavirus","volume":"36","author":"Sa\u2019ad","year":"2024","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0130","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1038\/s41598-022-20759-7","article-title":"Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein\/ACE2 interaction","volume":"12","author":"Singh","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110153_bb0135","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/ph15091046","article-title":"Potential coronaviral inhibitors of the nucleocapsid protein identified in silico and in vitro from a large natural product library","volume":"15","author":"Pohler","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110153_bb0140","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/molecules29061406","article-title":"Design, synthesis, and biological evaluation of novel coumarin Analogs targeted against SARS-CoV-2","volume":"29","author":"Sharma","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110153_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101702","article-title":"Synthesis, characterization, cytotoxicity, and antiviral activity of new coumarin analogues against coronavirus","volume":"10","author":"Auwal Sa\u2019ad","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ph13060111","article-title":"Novel 1,2,4-oxadiazole derivatives in drug discovery","volume":"13","author":"Biernacki","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110153_bb0155","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/j.bmc.2019.05.049","article-title":"Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent \u03b2-glucuronidase inhibitors and their molecular docking study","volume":"27","author":"Taha","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0160","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/ijms22052367","article-title":"1,2,4-oxadiazole-based bio-isosteres of benzamides: synthesis, biological activity and toxicity to zebrafish embryo","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0165","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4314","article-title":"Cytopathic effect assay and plaque assay to evaluate in vitro activity of antiviral compounds against human coronaviruses 229E, OC43, and NL63","volume":"12","author":"Hu","year":"2022","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.bioorg.2026.110153_bb0170","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1295","article-title":"Infectious focus assays and multiplicity of infection (MOI) calculations for alpha-herpesviruses","volume":"4","author":"Sloutskin","year":"2014","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.bioorg.2026.110153_bb0175","first-page":"52065","article-title":"Viral concentration determination through plaque assays: using traditional and novel overlay systems","author":"Baer","year":"2014","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.bioorg.2026.110153_bb0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2020.05.015","article-title":"Growth, detection, quantification, and inactivation of SARS-CoV-2","volume":"548","author":"Case","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.110153_bb0185","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4314","article-title":"Cytopathic effect assay and plaque assay to evaluate in vitro activity of antiviral compounds against human coronaviruses 229E, OC43, and NL63","volume":"12","author":"Hu","year":"2022","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.bioorg.2026.110153_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00956-23","article-title":"BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir","volume":"68","author":"Tang","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110153_bb0195","doi-asserted-by":"crossref","first-page":"L926","DOI":"10.1152\/ajplung.00374.2020","article-title":"Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells","volume":"319","author":"Loo","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0200","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024302118","article-title":"Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay","volume":"118","author":"Jang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102199","article-title":"Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication","volume":"48","author":"Du","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"M","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bioorg.2026.110153_bb0215","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/avj.13197","article-title":"Genomics and pathogenesis of the avian coronavirus infectious bronchitis virus","volume":"100","author":"Quinteros","year":"2022","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.bioorg.2026.110153_bb0220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/poultry2030027","article-title":"Infectious bronchitis virus (Gammacoronavirus) in poultry: genomic architecture, post-translational modifications, and structural motifs","volume":"2","author":"Bhuiyan","year":"2023","journal-title":"Poultry"},{"key":"10.1016\/j.bioorg.2026.110153_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103017","article-title":"Synthesis and biological evaluation of bromophenol derivatives with cyclopropyl moiety: ring opening of cyclopropane with monoester","volume":"89","author":"Boztas","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134135","article-title":"Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives","volume":"1272","author":"El Mansouri","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110153_bb0235","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/antibiotics12020306","article-title":"Synthesis, characterization, cytotoxicity analysis and evaluation of novel heterocyclic derivatives of benzamidine against periodontal disease triggering bacteria","volume":"12","author":"Kavitha","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2026.110153_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115242","article-title":"Design, synthesis, and biological evaluation of novel dihydropteridone derivatives possessing oxadiazoles moiety as potent inhibitors of PLK1","volume":"251","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0245","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/v16071097","article-title":"Translation inhibition mediated by interferon-stimulated genes during viral infections","volume":"16","author":"Smart","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.110153_bb0250","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2022.10.012","article-title":"Translation\u2014a tug of war during viral infection","volume":"83","author":"Rozman","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.110153_bb0255","doi-asserted-by":"crossref","first-page":"e02130","DOI":"10.1128\/AAC.02130-19","article-title":"Tryptophan trimers and tetramers inhibit dengue and zika virus replication by interfering with viral attachment processes","volume":"64","author":"Fikatas","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110153_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115272","article-title":"Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential","volume":"252","author":"Ayoup","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110153_bb0270","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-biochem-052521-115653","article-title":"The life of SARS-CoV-2 inside cells: replication-transcription complex assembly and function","volume":"91","author":"Lou","year":"2022","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112711","article-title":"The development of coronavirus 3C-like protease (3CLpro) inhibitors from 2010 to 2020","volume":"206","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0280","doi-asserted-by":"crossref","first-page":"e00841","DOI":"10.1128\/jvi.00841-22","article-title":"Proteolytic processing of the coronavirus replicase nonstructural protein 14 exonuclease is not required for virus replication but alters RNA synthesis and viral fitness","volume":"96","author":"Anderson-Daniels","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0285","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.14233\/ajchem.2024.31430","article-title":"In silico analysis of antiviral potential of new coumarin analogues against coronavirus","volume":"36","author":"Sa\u2019ad","year":"2024","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117004","article-title":"Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV -2","volume":"281","author":"Guma","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38445","article-title":"Mechanism of non-competitive inhibition of the SARS-CoV-2 3CL protease dimerization: therapeutic and clinical promise of the lichen secondary metabolite perlatolinic acid","volume":"10","author":"Fagnani","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2026.110153_bb0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acscentsci.2c01359","article-title":"Development of highly potent noncovalent inhibitors of SARS-CoV-2 3CLpro","volume":"9","author":"Hou","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0305","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.bioorg.2026.110153_bb0310","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"8","author":"Jose","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bioorg.2026.110153_bb0315","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/medicina58020144","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina (Mex)"},{"key":"10.1016\/j.bioorg.2026.110153_bb0320","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218083120","article-title":"Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses","volume":"120","author":"Otter","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110153_bb0325","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3390\/v15081655","article-title":"Airway epithelial-derived immune mediators in COVID-19","volume":"15","author":"Guo","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.110153_bb0330","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/thoraxjnl-2021-217561","article-title":"Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19","volume":"77","author":"Bridges","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.bioorg.2026.110153_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1222170","article-title":"Effect of antiviral and immunomodulatory treatment on a cytokine profile in patients with COVID-19","volume":"14","author":"Martonik","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0350","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/microorganisms9071479","article-title":"Possible targets of pan-coronavirus antiviral strategies for emerging or re-emerging coronaviruses","volume":"9","author":"Li","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.bioorg.2026.110153_bb0355","article-title":"Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: focus on molecular targets and clinical efficacy","volume":"10","author":"Dinda","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bioorg.2026.110153_bb0360","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: from discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0365","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1021\/tx300192g","article-title":"Importance of multi-P450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude and prediction from in vitro data","volume":"25","author":"Isoherranen","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110153_bb0370","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/ijms21134618","article-title":"An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities","volume":"21","author":"Annunziata","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110153_bb0375","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1021\/acs.jmedchem.6b00597","article-title":"Structure-based optimization of potent, selective, and orally bioavailable CDK8 inhibitors discovered by high-throughput screening","volume":"59","author":"Czodrowski","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110153_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105994","article-title":"The triple combination of remdesivir (GS-441524), molnupiravir and ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model","volume":"231","author":"Do","year":"2024","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110153_bb0385","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","article-title":"Drug combination therapy for emerging viral diseases","volume":"26","author":"Shyr","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.110153_bb0390","article-title":"Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo","volume":"239","year":"2025","journal-title":"Antiviral Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:45:46Z","timestamp":1787676346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":76,"alternative-id":["S0045206826006899"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110153","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin-derived oxadiazoles as potential antiviral agents against coronaviruses","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110153"}}